longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Medtronic

MDT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 22.53, below the reasonable range, cheaper than 91.63% of the time in the past 5 years, and the industry ranks 20/175, the industry Median -0.90.

22.53xP/E
$92.13Stock price
$4.09Earnings per share
22.53xP/E
Stock price$92.13Earnings per share$4.09

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
26.53x
Typical range
24.15x–29.32x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
22.53x26.73%$117.85B
SYKUSStryker
28.30x53.11%$105.53B
BSXUSBoston Scientific
17.10x36.60%$62.81B
RMDUSResmed
21.31x11.93%$32.46B
RYLPFUSKoninklijke Philips N.V.
17.79x--$23.01B
PHGUSKoninklijke Philips Elect
18.65x16.23%$24.12B
TRUMYUSTerumo
19.88x--$20.89B
STEUSSteris
24.83x17.10%$19.99B
ZBHUSZimmer Biomet
22.55x37.01%$18.19B
SNNUSSmith and Nephew
18.25x42.74%$11.59B
GMEDUSGlobus Medical Inc
18.58x6.02%$9.95B
PODDUSInsulet
25.98x76.42%$9.75B
SSMXYUSSysmex
28.26x--$7.15B
LIVNUSLivanova
22.79x189.82%$4.30B
TMDXUSTransMedics
19.75x71.39%$3.00B
INSPUSInspire Medical
16.44x100.88%$2.22B
LMATUSLemaitre Vascular
27.44x13.99%$1.80B
CNMDUSConmed
24.08x156.95%$1.36B
TCMDUSTactile
20.22x36.59%$502.88M
BWAYUSBrainsway
28.23x70.37%$266.56M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.